GlassScriptPhysician profile
Lawrence Jay Tremper
NPI 1003814211
$1,560.44
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,526 · 2020: $21.22 · 2022: $12.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $551.19 | 2019 | |
| Gilead Sciences, INC. | $296.15 | 2019 | |
| Chiesi USA, INC. | $240.67 | 2019-2022 | |
| Sobi, INC | $159.21 | 2019 | |
| Biogen, INC. | $98.87 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $91.44 | 2019 | |
| Abbvie INC. | $38.90 | 2019 | |
| Electromed, INC. | $25.21 | 2019 | |
| Advanced Respiratory, INC | $16.77 | 2019 | |
| Sarepta Therapeutics, INC. | $14.80 | 2019 | |
| Philips North America LLC | $14.21 | 2019 | |
| Allergan, INC. | $13.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Tremper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.